359 related articles for article (PubMed ID: 19497287)
21. Assessment of in vitro antimalarial interactions between dihydroartemisinin and fosmidomycin.
Chaijaroenkul W; Pruktal P; Muhamad P; Na-Bangchang K
Southeast Asian J Trop Med Public Health; 2007 Sep; 38(5):791-5. PubMed ID: 18041293
[TBL] [Abstract][Full Text] [Related]
22. Clarithromycin, a cytochrome P450 inhibitor, can reverse mefloquine resistance in Plasmodium yoelii nigeriensis- infected Swiss mice.
Tripathi R; Pandey SK; Rizvi A
Parasitology; 2011 Aug; 138(9):1069-76. PubMed ID: 21756423
[TBL] [Abstract][Full Text] [Related]
23. Synergistic interactions of the antiretroviral protease inhibitors saquinavir and ritonavir with chloroquine and mefloquine against Plasmodium falciparum in vitro.
Skinner-Adams TS; Andrews KT; Melville L; McCarthy J; Gardiner DL
Antimicrob Agents Chemother; 2007 Feb; 51(2):759-62. PubMed ID: 17088482
[TBL] [Abstract][Full Text] [Related]
24. In vitro efficacy of antimalarial drugs against Plasmodium vivax on the western border of Thailand.
Chotivanich K; Udomsangpetch R; Chierakul W; Newton PN; Ruangveerayuth R; Pukrittayakamee S; Looareesuwan S; White NJ
Am J Trop Med Hyg; 2004 Apr; 70(4):395-7. PubMed ID: 15100453
[TBL] [Abstract][Full Text] [Related]
25. [Assay of sensitivity of Plasmodium falciparum to chloroquine, amodiaquine, piperaquine, mefloquine and quinine in Yunnan province].
Yang H; Liu D; Huang K; Yang Y; Yang P; Liao M; Zhang C
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1999; 17(1):43-5. PubMed ID: 12563816
[TBL] [Abstract][Full Text] [Related]
26. Plasmodium falciparum: role of absolute stereochemistry in the antimalarial activity of synthetic amino alcohol antimalarial agents.
Karle JM; Olmeda R; Gerena L; Milhous WK
Exp Parasitol; 1993 Jun; 76(4):345-51. PubMed ID: 8513873
[TBL] [Abstract][Full Text] [Related]
27. In-vitro antimalarial activity of azithromycin against chloroquine sensitive and chloroquine resistant Plasmodium falciparum.
Biswas S
J Postgrad Med; 2001; 47(4):240-3. PubMed ID: 11832638
[TBL] [Abstract][Full Text] [Related]
28. Genetic analysis of mefloquine-resistant mechanism of Plasmodium falciparum.
Nishiyama Y; Okuda Y; Kim HS; Huruta T; Kimura M; Wataya Y
Nucleic Acids Symp Ser (Oxf); 2004; (48):163-4. PubMed ID: 17150529
[TBL] [Abstract][Full Text] [Related]
29. Application of multi-component reactions to antimalarial drug discovery. Part 1: Parallel synthesis and antiplasmodial activity of new 4-aminoquinoline Ugi adducts.
Musonda CC; Taylor D; Lehman J; Gut J; Rosenthal PJ; Chibale K
Bioorg Med Chem Lett; 2004 Aug; 14(15):3901-5. PubMed ID: 15225694
[TBL] [Abstract][Full Text] [Related]
30. Antimalarial efficacy and drug interactions of the novel semi-synthetic endoperoxide artemisone in vitro and in vivo.
Vivas L; Rattray L; Stewart LB; Robinson BL; Fugmann B; Haynes RK; Peters W; Croft SL
J Antimicrob Chemother; 2007 Apr; 59(4):658-65. PubMed ID: 17337512
[TBL] [Abstract][Full Text] [Related]
31. Effects of hydroxypyridinone iron chelators in combination with antimalarial drugs on the in vitro growth of Plasmodium falciparum.
Pattanapanyasat K; Kotipun K; Yongvanitchit K; Hider RC; Kyle DE; Heppner DG; Walsh DS
Southeast Asian J Trop Med Public Health; 2001 Mar; 32(1):64-9. PubMed ID: 11485097
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from Gabon.
Kreidenweiss A; Kremsner PG; Mordmüller B
Malar J; 2008 Sep; 7():187. PubMed ID: 18816382
[TBL] [Abstract][Full Text] [Related]
33. In vitro activity of iron-binding compounds against Senegalese isolates of Plasmodium falciparum.
Pradines B; Tall A; Ramiandrasoa F; Spiegel A; Sokhna C; Fusai T; Mosnier J; Daries W; Trape JF; Kunesch G; Parzy D; Rogier C
J Antimicrob Chemother; 2006 Jun; 57(6):1093-9. PubMed ID: 16595639
[TBL] [Abstract][Full Text] [Related]
34. In vitro susceptibility studies of Malaysian Plasmodium falciparum isolates and clones against schizontocidal drugs.
Ang HH; Chan KL; Mak JW
Folia Parasitol (Praha); 1998; 45(3):196-8. PubMed ID: 9805783
[TBL] [Abstract][Full Text] [Related]
35. Identification of putative Plasmodium falciparum mefloquine resistance genes.
Jeffress M; Fields S
Mol Biochem Parasitol; 2005 Feb; 139(2):133-9. PubMed ID: 15664648
[TBL] [Abstract][Full Text] [Related]
36. [Fluctuation in the resistance of Plasmodium falciparum to chloroquine in China].
Liu DQ; Feng XP; Yang HL; Lin SG; Chen WJ; Yang PF
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2005 Feb; 23(1):27-31. PubMed ID: 16042203
[TBL] [Abstract][Full Text] [Related]
37. Effects of dipyridamole on Plasmodium falciparum-infected erythrocytes.
Akaki M; Nakano Y; Ito Y; Nagayasu E; Aikawa M
Parasitol Res; 2002 Dec; 88(12):1044-50. PubMed ID: 12444453
[TBL] [Abstract][Full Text] [Related]
38. The antimalarial potential of 4-quinolinecarbinolamines may be limited due to neurotoxicity and cross-resistance in mefloquine-resistant Plasmodium falciparum strains.
Dow GS; Koenig ML; Wolf L; Gerena L; Lopez-Sanchez M; Hudson TH; Bhattacharjee AK
Antimicrob Agents Chemother; 2004 Jul; 48(7):2624-32. PubMed ID: 15215119
[TBL] [Abstract][Full Text] [Related]
39. The potential use of methotrexate in the treatment of falciparum malaria: in vitro assays against sensitive and multidrug-resistant falciparum strains.
Dar O; Khan MS; Adagu I
Jpn J Infect Dis; 2008 May; 61(3):210-1. PubMed ID: 18503171
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of antimalarial activity of chloramphenicol against Indian Plasmodium falciparum isolates in vitro by chloroquine.
Biswas S
Indian J Malariol; 2002; 39(1-2):26-33. PubMed ID: 14686107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
